US SB2082 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 16 2021 - 25% progression, died in committee
Action: 2021-06-16 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 16 2021 - 25% progression, died in committee
Action: 2021-06-16 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.
Title
MADE in America Act Manufacturing API, Drugs, and Excipients in America Act
Sponsors
| Sen. Tim Scott [R-SC] | Sen. Jacky Rosen [D-NV] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-06-16 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB3927 (Same As) 2021-06-17 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/2082/all-info |
| Text | https://www.congress.gov/117/bills/s2082/BILLS-117s2082is.pdf |
